|
EED expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.565800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.876400E-01 |
| Normal-vs-Stage2 |
1.803210E-01 |
| Normal-vs-Stage3 |
6.926800E-01 |
| Normal-vs-Stage4 |
7.688600E-01 |
| Stage1-vs-Stage2 |
2.002600E-01 |
| Stage1-vs-Stage3 |
7.734600E-01 |
| Stage1-vs-Stage4 |
7.936400E-01 |
| Stage2-vs-Stage3 |
1.597780E-01 |
| Stage2-vs-Stage4 |
4.872000E-01 |
| Stage3-vs-Stage4 |
6.547600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.679200E-01 |
| Normal-vs-AfricanAmerican |
4.700000E-01 |
| Normal-vs-Asian |
2.092600E-01 |
| Caucasian-vs-AfricanAmerican |
5.021800E-01 |
| Caucasian-vs-Asian |
2.153000E-01 |
| AfricanAmerican-vs-Asian |
6.884000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.897000E-01 |
| Normal-vs-Female |
2.199800E-01 |
| Male-vs-Female |
1.531650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.356800E-01 |
| Normal-vs-Extreme_Weight |
5.048000E-01 |
| Normal-vs-Obese |
8.283800E-01 |
| Normal-vs-Extreme_Obese |
4.776800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.625210E-01 |
| Normal_Weight-vs-Obese |
4.180200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.980200E-01 |
| Extreme_Weight-vs-Obese |
3.831000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.153000E-01 |
| Obese-vs-Extreme_Obese |
3.561800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.228300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.791200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.901200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.600100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.714280E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.117350E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.778900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.716100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.971600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.104600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.995800E-01 |
| Normal-VS-Type2 PRCC |
7.183900E-02 |
| Normal-VS-KIRP CIMP |
1.288550E-01 |
| Normal-VS-Unclassified PRCC |
5.402800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.383850E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.142160E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.791600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.336200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.249700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.608230E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.827600E-01 |
| Normal-vs-N1 |
1.801790E-01 |
| Normal-vs-N2 |
2.684000E-02 |
| N0-vs-N1 |
1.046810E-01 |
| N0-vs-N2 |
1.413390E-01 |
| N1-vs-N2 |
8.560000E-02 |
|
|
